Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255606 | SCV000322416 | pathogenic | not provided | 2024-12-05 | criteria provided, single submitter | clinical testing | Observed in a patient with atopic dermatitis in published literature (PMID: 24608987); Nonsense variant predicted to result in protein truncation, as the last 653 amino acid(s) are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 29428354, 28407221, 31365035, 32018027, 31589614, 24608987, 16444271) |
Baylor Genetics | RCV001332077 | SCV001524279 | likely pathogenic | Ichthyosis vulgaris | 2019-01-15 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported in an African American child with atopic dermatitis [PMID 24608987] |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003137870 | SCV003806999 | pathogenic | Dermatitis, atopic, 2 | 2022-10-12 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PVS1 strong, PS4 strong, PM2 supporting |
Genome- |
RCV001332077 | SCV004049856 | likely pathogenic | Ichthyosis vulgaris | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genetics and Genomic Medicine Centre, |
RCV001332077 | SCV005873731 | likely pathogenic | Ichthyosis vulgaris | 2021-03-25 | criteria provided, single submitter | clinical testing |